Elite Pharmaceuticals, Inc. ELTP

Company Overview

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, manufacture, and commercialization of generic pharmaceutical products, with a primary emphasis on controlled-release and abuse-deterrent drug technologies. The company operates within the pharmaceutical and drug manufacturing industries and derives revenue primarily from the sale of generic prescription products, manufacturing and licensing agreements, and product development collaborations. Its portfolio has historically included products in therapeutic categories such as central nervous system disorders, pain management, and cardiovascular treatments.

The company’s business model combines in-house research and development with commercial manufacturing capabilities. Elite has positioned itself around niche generic products and proprietary delivery technologies designed to improve dosing control and support abuse-deterrent formulations. Founded in 1997 and headquartered in Northvale, New Jersey, the company evolved from a development-stage pharmaceutical enterprise into a commercial-stage generic drug manufacturer with FDA-approved products and manufacturing operations in the United States.